The Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Sales Forecasts
Ginkgo Bioworks: Another Lost Year
How The Ginkgo Bioworks (DNA) Story Is Shifting After The Biosecurity Divestiture And Target Cut
Ginkgo Bioworks Q1 Earnings Call Highlights
Ginkgo Bioworks Holdings (NYSE:DNA) tumbles 15% in after-hours trading after Q1 revenue and earnings miss analyst estimates
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
Ginkgo Bioworks: Shedding Biosecurity And Doubling Down On Autonomy
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
Ginkgo Bioworks Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
Ginkgo Bioworks Rolls Out Ginkgo Cloud Lab
Ginkgo Bioworks Makes Major Pivot
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration
Ginkgo Bioworks Q4 Earnings Call Highlights
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ...
Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.